All updates
All updates
today 32文献与产业新闻精选评分6464 文献与产业新闻评分1414 STAT+: New documents reveal problems with Medicare’s prior-authorization pilot
文献与产业新闻评分1818 Businesses can now apply for NIH funding
文献与产业新闻评分1313 MHRA and Malaysia strengthen partnership on healthcare innovation and research
FDA Press Releases评分4141 FDA Launches Expedited IND Pilot, Begins Accepting Applications
文献与产业新闻精选评分6161 FDA approves first radioligand equivalent, Curium’s copycat of Novartis’ Lutathera
文献与产业新闻评分3030 STAT+: Medicare’s AI prior authorization pilot was rushed and full of problems, new documents reveal
中文产业新闻精选Chinese source评分6969 NMPA批准德曲妥珠单抗联合帕妥珠单抗方案用于HER2阳性晚期乳腺癌一线治疗
中文产业新闻精选Chinese source评分6868 武田Zasocitinib（TAK-279）银屑病NDA获FDA受理并获优先审评
中文产业新闻精选Chinese source评分6666 国家医保局试行新技术价格预立项制度，申报门槛放宽至三级医院
文献与产业新闻精选评分6666 After rejection, FDA approves Telix’s Pixclara, the first FET-PET imaging drug for brain cancer
中文产业新闻精选Chinese source评分6969 Scholar Rock肌肉靶向疗法Apitegromab获FDA批准
中文产业新闻Chinese source评分6060 恒瑞医药靶向FXI单抗SHR-2004申报TKA术后VTE预防上市
中文产业新闻精选Chinese source评分7373 国家医保局试行高水平新技术医疗服务价格预立项制度
文献与产业新闻精选评分7070 Judge blocks Trump administration plans to limit visa length for grad students, postdocs
文献与产业新闻评分2121 Psychedelics at FDA, Mike Davis’ CDER and translating tRNAs — a BioCentury podcast
文献与产业新闻精选评分4545 As ‘cultural weight’ of a psychedelic approval looms, FDA hearing focuses on access and safety
文献与产业新闻评分3030 As ‘cultural weight’ of a psychedelic approval looms, FDA hearing focuses on access and safety
文献与产业新闻评分2525 Kennedy to deliver keynote for anti-vaccine group he once led
文献与产业新闻精选评分7070 FDA could approve psychedelics before redosing is resolved
顶刊论文（社媒热度）精选评分5656 Moderna flu vaccine wins FDA approval.
文献与产业新闻评分2020 Pennsylvania records third measles-related death amid outbreak
文献与产业新闻精选评分7474 Scholar Rock scores long-awaited FDA approval, the first for muscle loss in SMA
文献与产业新闻评分99 The GOP’s $50 billion rural health fund is coming up short, hospital leaders say
中文产业新闻精选Chinese source评分6767 武田 Zasocitinib（TAK-279）斑块状银屑病 NDA 获 FDA 受理并给予优先审评
文献与产业新闻精选评分2929 STAT+: Trump’s secretive pharma deals may undermine ‘most-favored nation’ pricing, an analysis suggests
中文产业新闻精选Chinese source评分6161 诺和诺德司美格鲁肽获中国首批 MASH 适应症
中文产业新闻精选Chinese source评分6868 廖宁教授综合评估 DB09 试验：T-DXd 联合帕妥珠单抗一线治疗 HER2 阳性 mBC 获 NMPA 批准
文献与产业新闻精选评分7272 STAT+: Scholar Rock wins FDA approval for first drug to target SMA muscle loss
文献与产业新闻评分2929 STAT+: Pharma wins a battle over the cost of wastewater treatment in Europe
文献与产业新闻评分55 U.S. officials declare an end to record-setting cyclospora outbreak, but its origin is still unknown
文献与产业新闻评分3737 Medicaid will let states use ‘tiers’ to determine medical frailty
顶刊论文（社媒热度）精选评分5353 UK regulator plans to withdraw controversial vasculitis drug Tavneos over unreliable data.
文献与产业新闻评分2727 After FDA nod for novel Cabometyx formulation, analysts predict limited threat to Exelixis
中文产业新闻精选Chinese source评分7575 诺和诺德司美格鲁肽获批用于伴中重度肝纤维化的MASH患者
中文产业新闻精选Chinese source评分6262 第7批国家耗材集采开标：首次纳入消化介入23类，超9成中选，2027年1月执行
中文产业新闻精选Chinese source评分6363 徕博科将于美国推出罗氏诊断FDA批准的首个阿尔茨海默病pTau-217血液检测
中文产业新闻精选Chinese source评分7373 Intellia lonvo-z 体内 CRISPR 疗法 HAE 适应症获 FDA 优先审评受理
中文产业新闻精选Chinese source评分6363 司美格鲁肽注射液获中国首个代谢相关脂肪性肝炎适应症批准